The HPV vaccine has often been talked about as “the cervical cancer shot” for girls. But we now know it can be just as important for boys and men—and new research is putting numbers behind that benefit.

A recent study highlighted by CNN found that men who received the human papillomavirus (HPV) vaccine had a 46% lower risk of developing HPV-related cancers. That’s a striking reduction for cancers that are often preventable, yet many boys and men still aren’t getting vaccinated.

In this guide, we’ll walk through what HPV is, why vaccination matters for males, what the latest science is telling us, and how you (or your son, partner, or patient) can decide on next steps without fear, pressure, or misinformation.

A health care professional discussing HPV vaccination with a male patient
A clinician discusses HPV vaccination with a young adult male. Research shows significant cancer risk reduction for vaccinated men.

HPV isn’t just a “women’s issue”: why that misconception is harmful

HPV (human papillomavirus) is the most common sexually transmitted infection worldwide. Most sexually active people—men and women—will be exposed at some point. In many cases, the immune system clears the virus on its own. But in others, certain “high-risk” HPV types can lead to cancer years later.

For women, this connection is well known because of cervical cancer. For men, the link is often overlooked, even though HPV can cause:

  • Oropharyngeal (throat, tonsil, and base-of-tongue) cancers
  • Anal cancer
  • Penile cancer
  • Genital warts in all genders

Because the vaccine was initially promoted around cervical cancer prevention, many families—and even some adults—have come to believe it’s “for girls.” That misconception leaves a large group of people, especially boys and young men, underprotected.


What the latest research shows: a 46% lower risk of HPV-related cancers in men

The CNN report you’re reading about is based on new research that followed men over time and compared those who received the HPV vaccine with those who did not. The findings:

  • Men who had been vaccinated had a 46% reduction in HPV-related cancers compared with unvaccinated men.
  • The protection extended across several cancer types known to be caused by high‑risk HPV strains.
  • The benefits were greatest when vaccination occurred at younger ages, before substantial HPV exposure.

These results fit with a growing body of evidence from multiple countries showing that HPV vaccination leads to:

  1. Fewer HPV infections with high-risk strains
  2. Sharp declines in genital warts
  3. Reductions in pre-cancerous lesions and, over time, cancers themselves
“HPV vaccination has the potential to prevent the majority of HPV-related cancers in both women and men.” — U.S. Centers for Disease Control and Prevention (CDC)

For more background, see overviews from the CDC on HPV vaccination and the World Health Organization’s HPV fact sheet.


How the HPV vaccine works—for boys, teens, and men

Current HPV vaccines (like the widely used 9‑valent vaccine, often called Gardasil 9) target the HPV types most likely to cause cancer and genital warts. The vaccine uses virus‑like particles—it does not contain live virus and cannot cause HPV infection.

When someone gets the HPV shot, their immune system learns to recognize these HPV types and builds antibodies. Later, if they’re exposed to HPV through sexual contact, their body can often prevent the virus from establishing a long‑term infection.

HPV vaccines train the immune system to recognize and block high-risk HPV types before they can cause persistent infection and cancer.

For boys and men, this translates into:

  • Lower chance of acquiring cancer‑causing HPV strains
  • Reduced risk of genital warts
  • Lower risk of passing HPV to current or future partners

Who should consider the HPV vaccine? Guidance for boys and men

Exact recommendations differ a bit by country, but many expert groups, including the CDC and numerous national immunization programs, offer similar guidance for males:

  • Routine vaccination for boys around ages 11–12 (often starting as early as 9).
  • Catch‑up vaccination for teens and young adults who were not vaccinated earlier, typically up to age 26.
  • Shared decision‑making for some adults in their late 20s or early 30s who may still benefit, depending on their sexual history and risk factors.

The idea is simple: vaccinate before someone is likely to be exposed to HPV. But even sexually active people who haven’t been vaccinated yet may still get some protection, because they are unlikely to have been exposed to all of the HPV types covered by the vaccine.

“I’d much rather have an honest conversation with a 19‑year‑old man about partial protection than let the perfect be the enemy of the good. Some protection is still meaningful, especially for high‑risk HPV types.” — Family physician (case discussion, anonymized)

A real‑world example: a family’s decision to vaccinate their son

A few years ago, a pediatrician described a conversation with parents of a 12‑year‑old boy, Alex (name changed). They had vaccinated their daughter against HPV but hadn’t realized the shot was recommended for boys too.

Their questions were familiar:

  • “Isn’t this just for cervical cancer?”
  • “He’s not sexually active yet—can’t we wait?”
  • “Are there long‑term side effects we don’t know about?”

The doctor explained that:

  1. HPV causes cancers in men as well as women.
  2. The vaccine works best before exposure, which is why it’s recommended in early adolescence.
  3. Side effects are usually mild and short‑lived, mainly a sore arm, headache, or fatigue.

After discussing the pros and cons, Alex and his parents chose to start the HPV series. The decision wasn’t about assuming his future behavior—it was about giving him a safer future, whatever that behavior turned out to be.

Teenage boy and parent speaking with a doctor in a clinic
Many families only learn that HPV vaccination is recommended for boys during routine checkups—open conversation helps support informed decisions.

Common concerns about the HPV vaccine in men—and what the evidence says

It’s absolutely reasonable to have questions, especially about a vaccine that’s often associated with sexual health. Here are some of the most frequent concerns from boys, men, and parents, with what large studies and expert bodies have found so far.

1. “Is the HPV vaccine safe for boys and men?”

Extensive safety monitoring in millions of people has found that the HPV vaccines in use today have a strong safety profile. Typical side effects include:

  • Soreness, redness, or swelling where the shot is given
  • Mild fever
  • Headache or fatigue
  • Occasional fainting, particularly in teens (also seen with other vaccines)

Serious side effects are rare. Large reviews by organizations such as the CDC, the European Medicines Agency, and the World Health Organization have not found evidence that HPV vaccination increases the risk of infertility, autoimmune diseases, or chronic fatigue syndromes.

2. “Will this encourage teens to have sex earlier?”

Studies looking at sexual behavior before and after HPV vaccination have not found increases in early sexual activity, number of partners, or sexually transmitted infections. In other words, giving the vaccine does not appear to change when or how teens choose to be sexually active.

3. “If I’m older or already sexually active, is it too late?”

Not necessarily. While the vaccine is most effective when given before exposure, adults may still benefit. Many official guidelines support vaccination up to age 26, and some suggest a discussion up to age 45 for certain people. The exact benefit for older adults can vary, so this is a good topic to explore with your clinician.


Practical steps: how boys and men can get the HPV vaccine

Turning information into action can feel overwhelming, especially when you’re juggling school, work, or family responsibilities. Here’s a step‑by‑step approach that many people find manageable.

  1. Check your vaccination records.
    Look at your immunization card, electronic health portal, or ask previous clinics whether you’ve already received HPV doses.
  2. Schedule a visit (in person or virtual).
    A family doctor, pediatrician, internal medicine doctor, or sexual health clinic can all discuss HPV vaccination and either give the shot or refer you.
  3. Discuss timing and dosing.
    Confirm how many doses you need and when. Set reminders on your phone or calendar so you complete the series.
  4. Ask about coverage and cost.
    In many countries, HPV vaccination for eligible ages is covered by public programs or private insurance. Ask about costs up front so there are no surprises.
  5. Plan for mild side effects.
    Soreness or fatigue are common. Consider scheduling the shot on a lighter day, and keep water and over‑the‑counter pain relief available if you use it and your doctor says it’s safe for you.
Nurse preparing an injection in a clinical setting
Completing the full HPV vaccine series—two or three doses, depending on age—is key to strong and long‑lasting protection.

Overcoming common barriers: stigma, myths, and access

Even with strong evidence, real‑life obstacles can get in the way. If you’ve struggled with any of these, you’re not alone.

  • Stigma and discomfort talking about sexual health
    Try framing HPV vaccination not as a judgment about behavior, but as a routine cancer‑prevention step—similar to seatbelts or sunscreen.
  • Misinformation online
    Algorithm‑driven feeds can amplify dramatic stories rather than accurate data. When in doubt, cross‑check with sources like the CDC or the American Cancer Society.
  • Limited access or cost concerns
    Community health centers, school clinics, or national programs sometimes offer free or low‑cost HPV vaccination. Ask your provider about local options.
  • Cultural or family beliefs
    Gentle, ongoing conversations often work better than one high‑pressure talk. Focusing on cancer prevention, rather than sexual activity, can help align with shared values.

What the science supports—and what we still don’t know

As of 2026, multiple independent research groups and public health agencies converge on several key points about HPV vaccination in males:

  • HPV is a major cause of several cancers in men, particularly certain throat, anal, and penile cancers.
  • Vaccinated males have substantially fewer HPV infections with covered types and lower rates of genital warts.
  • Emerging data, like the study highlighted by CNN, show meaningful reductions in HPV‑related cancers among vaccinated men (around 46% in the reported analysis).
  • The vaccines show a strong safety record in large‑scale monitoring across multiple countries.

At the same time, scientists are still:

  • Tracking long‑term cancer outcomes over decades, as these cancers can take many years to develop.
  • Studying how long protection lasts and whether booster doses might ever be needed.
  • Refining which ages and risk groups get the greatest benefit from late vaccination.
Ongoing research continues to refine our understanding of how HPV vaccination lowers cancer risk in men over a lifetime.

No vaccine can guarantee that someone will never develop cancer. But for many boys and men, the HPV vaccine appears to substantially lower the risk of specific, HPV‑driven cancers with a relatively small short‑term burden—usually just a few shots and a day or two of minor soreness.


Taking the next step: a conversation worth having

If there’s one takeaway from the emerging research, it’s this: HPV vaccination isn’t just a women’s health issue—it’s cancer prevention for everyone, including boys and men.

You don’t have to decide today, and you don’t have to decide alone. But you deserve clear, balanced information and a chance to ask questions that matter to you.

Consider doing one of these in the next week:

  • If you’re a parent, add “Ask about HPV vaccine for my son” to your list for his next checkup.
  • If you’re a teen or young man, send a message through your clinic portal asking whether you’re eligible.
  • If you’re an adult man who’s unsure, schedule a quick visit—virtual or in person—to review your options.

Those few minutes of conversation could translate into a meaningful reduction in cancer risk down the road. That’s a quiet, powerful investment in your future self—and in the health of the people you care about.